cagrisema vs tirzepatide vs Retatrutide: Comparing Next-Generation Metabolic Peptides Novo Nordisk's CagriSema Delivers 23%

Samson SL, Vellanki P, Blonde L, Christofides EA, Galindo RJ, Hirsch IB et al (2023) American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update

Theyll target $145/month via Medicare/Medicaid/TrumpRx

The human digestive system is quite efficient at breaking things down

Regular medical supervision, honest communication with your doctor, and close attention to your bodys signals can significantly reduce risks while maximising benefits

Type 2 Diabetes c

PMID: Summary Keywords GIP/GLP-1 receptor agonist, glucagon-like peptide 1 receptor agonist, glucocorticosteroids, semaglutide, steroid-induced diabetes, steroid-induced hyperglycaemia Citation Jdrasek A, Lisowska K and Czupryniak L (2026) Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes: a narrative review